Vestal Point Capital’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Hold |
635,000
| – | – | 0.08% | 64 |
|
|
2025
Q1 | $2.73M | Hold |
635,000
| – | – | 0.2% | 50 |
|
|
2024
Q4 | $5.46M | Buy |
635,000
+555,060
| +694% | +$4.77M | 0.32% | 52 |
|
|
2024
Q3 | $1.36M | Buy |
79,940
+25,440
| +47% | +$432K | 0.1% | 64 |
|
|
2024
Q2 | $823K | Buy |
54,500
+24,962
| +85% | +$377K | 0.06% | 59 |
|
|
2024
Q1 | $490K | Sell |
29,538
-10,462
| -26% | -$174K | 0.04% | 56 |
|
|
2023
Q4 | $640K | Buy |
+40,000
| New | +$640K | 0.07% | 41 |
|